Riyaz Bashir, MD, FACC, RVT, Professor of Medicine at the Lewis Katz School of Medicine at Temple University and Director of Vascular and Endovascular Medicine at Temple University Hospital, provided comments to Reuters Health about study findings examining the use of rivaroxaban plus aspirin for patients with vascular disease and moderate renal dysfunction. Dr. Bashir was not involved in the original COMPASS trial or the secondary study. MD Alert picked up the Reuters Health piece.
Temple Faculty Physicians is experiencing technical issues with phone lines. If you are experiencing an emergency, please visit your nearest emergency room. If you would like to schedule an appointment with your provider or have general questions or requests, please contact us by using myTempleHealth.
myTempleHealth
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH